HS Code for Alkaloid medicine

Alkaloid medicines are classified under HS code 300449. This code falls within Chapter 30, which covers "Pharmaceutical products." Specifically, heading 3004 addresses "Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale." Subheading 300449 is for "Medicaments containing alkaloids or their derivatives, other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts; for therapeutic or prophylactic uses, packaged for retail sale." This classification is precise for finished pharmaceutical products containing alkaloids, provided they do not contain the specifically excluded substances.

Products Included

• Morphine-based pain relievers
• Codeine-based cough suppressants (excluding those with ephedrine/pseudoephedrine)
• Quinine-based antimalarials
• Atropine-based ophthalmic preparations
• Vinca alkaloid chemotherapy drugs

Common Misclassification

Common misclassifications arise from the specific exclusions within the heading. Medicaments containing ephedrine or its salts are classified under HS 300441, not 300449. Similarly, those containing pseudoephedrine or norephedrine are classified under HS 300442. Another frequent error is confusing finished medicaments with raw alkaloids. HS 2939 covers "Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives," which refers to the bulk active pharmaceutical ingredients (APIs), not prepared medicaments packaged for retail sale. The distinction lies in whether the product is a raw chemical or a finished pharmaceutical product.

FAQ

What is the HS code for Alkaloid medicine?

The HS code for Alkaloid medicine is 300449.

What does "packaged for retail sale" mean in this context?

In this context, "packaged for retail sale" signifies that the medicament is put up in measured doses or in forms or packings intended for direct use by the consumer without further processing. This includes blister packs, bottles of tablets, or pre-filled syringes, as opposed to bulk quantities for pharmaceutical manufacturing.